Isosorbide Mononitrate Accord Healthcare

Isosorbide Mononitrate, the active ingredient in Isosorbide Mononitrate Accord Healthcare, is an organic nitrate presented as an oral tablet for oral use. It is employed to prevent episodes of chest pain in patients with chronic stable angina and to improve symptoms in certain forms of heart failure.

GNH USA supplies Isosorbide Mononitrate Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Isosorbide Mononitrate is used in the management of cardiovascular conditions that involve myocardial oxygen demand.

- Chronic stable angina: reduces the frequency of angina attacks by decreasing cardiac preload and afterload. - Heart failure with reduced ejection fraction: improves exercise tolerance and lessens dyspnea in patients with chronic heart failure.

Isosorbide Mononitrate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache - Dizziness - Flushing - Nausea - Hypotension - Palpitations

Serious or Rare Side Effects: - Severe hypotension - Syncope - Methemoglobinemia - Allergic reactions such as rash or angioedema - Tachycardia - Rare myocardial infarction

Use of isosorbide mononitrate requires careful assessment of patient-specific factors.

- Dose adjustment: required in patients with severe hepatic impairment. - Renal function: use caution in severe renal impairment. - Concomitant nitrates: avoid concurrent use due to additive hypotensive effect. - Phosphodiesterase‑5 inhibitors: contraindicated because of risk of profound hypotension. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Isosorbide mononitrate interacts with several drug classes that can amplify its vasodilatory action.

Major Interactions (Avoid): - Other organic nitrates (e.g., nitroglycerin) – may cause severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil) – risk of profound blood pressure drop. - Potent intravenous antihypertensives (e.g., nitroprusside) – additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Loop diuretics – may enhance hypotensive response. - Other antihypertensive agents (beta‑blockers, ACE inhibitors) – monitor blood pressure. - Alcohol – can increase vasodilatory side effects such as dizziness and flushing.